Statistics from Altmetric.com
THE European Medicines Agency (EMA) has announced that it is reviewing the veterinary medicine Velactis (Ceva Santé Animale) following reports of serious adverse events following its use in dairy cattle.
Velactis, a prescription-only veterinary medicine containing the active substance cabergoline, is used in the management of dairy cows as an aid in abrupt drying off, by reducing milk production. It was authorised through the EMA in December 2015 and was first sold in the UK in April this year.
The EMA said on June 24 that it had been informed by Ceva Santé Animale, the marketing …